Coming Soon! IEC Welcomes PhDs

Eligibility Expanding in 2025
In recognition of the importance PhDs play in the research of atopic dermatitis, the IEC is again expanding its membership eligibility criteria to include these vital researchers! Follow us on social media for the official announcement and details to come!

Latest IEC article published on JAK inhibitors.   

The IEC is pleased to announce that the British Journal of Dermatology published the Council’s most recent manuscript, A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council, on September 10. With 31 authors, this open-access article draws on the global expertise of the Council to create a consensus opinion on a pragmatic approach to prescribing janus kinase inhibitors (JAKinibs), including appropriate patients, dosing, clinical and lab monitoring, and long-term use. JAKinibs hold great potential for treatment of moderate to severe atopic dermatitis but must be fully understood before prescribing.

For all IEC publications, see our expanded list.

The International Eczema Council continues to grow. 

The IEC Board of Directors is proud to announce the following new members were approved at the March 2024 and July 2024 Board of Directors meetings.

Learn More

IEC Symposium at RADLA, SID and EAACI webcasts are now available on-demand. Click below to view.  

Watch RADLA On-Demand Webcast

Watch SID On-Demand Webcast

Watch EAACI On-Demand Webcast

IEC Launches International Fellowship Program: Clinical and Research Opportunities Worldwide

Learn More and Apply Today

IEC Announces New 3 Year Strategic Plan

At the end of 2023, the IEC developed a new strategic plan. This in-depth process involved IEC leadership, Councilors, Associates and Industry Partners as we sought input through surveys and other methods. 

Learn More